Kidney tumors are the general term for various types of kidney tumors. Kidney tumors include benign tumors and malignant tumors. Malignant tumors in the kidney are what we call kidney cancer. Both benign tumors and malignant tumors are very different in terms of symptoms and treatment. Therefore, only when the difference between the two diseases is clarified, can we better diagnose and treat kidney tumor diseases. What is the difference between the two, let''s take a look:

　　benign renal tumors are most commonly renal cysts and renal hamartomas. Kidney cysts are rare in young people, because kidney cysts are actually tubular diverticulum, and as people age, this diverticulum may become larger and larger. The size of the newly developed kidney cyst is generally between 1-2cm, which will not cause discomfort to the human body and will not affect the kidney function. It only needs to be reviewed regularly. However, when the cyst gradually grows, especially when it exceeds 5cm, it is dangerous, because an excessively large cyst may exert pressure on the surrounding renal parenchyma and affect kidney function. In addition to the size, the location of the kidney cyst is also important. If the kidney cyst is close to the renal pelvis, it will cause hydronephrosis.

　　 Renal hamartoma is also a benign renal tumor, also known as renal vascular smooth muscle lipoma, which is more common in women. Patients with renal hamartoma generally do not have symptoms of discomfort. No treatment is required for renal hamartoma less than 4 cm, and regular imaging examinations such as ultrasound and CT are sufficient. When it is observed that the volume of renal hamartoma is greater than 4cm, surgical treatment is required, because the excessive volume of hamartoma will exert pressure on normal kidney tissue and affect renal function. At the same time, hamartoma has the risk of rupture and bleeding due to external force.

　　Malignant kidney tumors are the most upsetting for us, because malignant kidney tumors have the characteristics of invasive growth and distant metastasis, which can cause multiple organ failure and threaten life. Faced with malignant kidney tumors, We must actively treat. Malignant kidney tumors are also called kidney cancers, and are mostly renal cell carcinomas. With the improvement of medical standards, these types of cancers can also be found in routine physical examinations.

　　Whether it is a benign kidney tumor or kidney cancer, patients with blood selenium levels will be life-threatening if they drop: Clinically, they are combined with Hecun malt selenium capsules for cancer patients. Selenium is called "anti-cancer" "September 2003" The US Food and Drug Administration (FDA) recognized selenium as a cancer suppressant. This is the official medical statement from the US government that selenium can suppress cancer. Scientists have supplemented selenium for cancer patients for a long time, which has reduced the mortality rate of cancer patients by 50%. A large number of studies have shown that selenium is a powerful tumor inhibitor, which can inhibit the growth of cancer cells and block the energy supply of cancer cells. At present, many scholars believe that selenium is not only effective in cancer prevention, but also can be used as an adjuvant to chemotherapy, reduce the side effects of chemotherapy drugs, and increase drug tolerance.

　　The level of blood selenium is also related to the recurrence rate of cancer, the degree of spread, the survival time of patients and the prognosis. For patients with tumors with high blood selenium levels, the tumor may be limited to the primary site, the possibility of distant metastasis is less, the recurrence rate may be lower, and the prognosis may be better. In contrast, patients with significantly reduced blood selenium are more likely to have distant metastasis, high malignancy, and short survival time. The selenium content of cancer patients is lower than that of normal people. Hecun malt selenium capsules have high selenium content, which is suitable for cancer patients.